必应词典为您提供concomitant-drugs的释义,网络释义: 伴随药物;随同药物;
The present invention relates to a pharmaceutical agent containing one or more kinds of a p38 MAP kinase inhibitor and/or a TNF-伪 production inhibitor and one or more kinds of drugs selected from the group consisting of (1) a non-steroidal antiinflammatory drug, (2) a disease-modifying ...
Concomitant drugs refer to the simultaneous or successive use of two or more drugs in order to achieve the purpose of treatment, and the main result is to enhance the drug efficacy or to decrease the drug side effects. From: Pharmacological Research, 2022 ...
分享到: 伴随药物 分类: 医学|查看相关文献(pubmed)|免费全文文献 详细解释: 以下为句子列表: 分享到:
Genetic factorsplay an as yet poorly defined role in therapeutic drug monitoring, as is the case of the poor ability of some racial groups to acetylate drugs Concomitant disease, ie whether there are underlying conditions that may affect drug distribution or metabolism, eg renal disease with ↓ ...
Treatment programs need to pay attention to concomitant drugs of abuse.doi:10.1016/0741-8329(85)90134-XZeiner, Arthur R.Stanitis, TomSpurgeon, MoiraNichols, NancyElsevier Inc.AlcoholZeiner AR, Stanitis T, Spurgeon M, Nichols N. Treatment of alcoholism and concomitant drugs of abuse. Alcohol. ...
aThe patients wereinstructed to apply the study drug topically to the acne lesions, twice a day, after washing the face in the morning and evening without the use of any concomitant drugs. 患者wereinstructed应用研究药物典型地于粉刺损害,每日两次,在洗面孔早晨和以后,不用对所有伴随药物的用途。[tran...
Simultaneous treatment of depression and other diseases leads to the use of several drugs from different therapeutic groups [8,9]. At the same time, antidepressants are known for their everyday interaction with other medications and causing hurt comorbidities (drug-disease interactions), posing a thr...
GRE/TOEFL 英[kənˈkɒmɪtənt] 美[kənˈkɑmɪtənt] 释义 adj. 伴随的,同时发生或出现的 n. 伴随发生的事;伴随物;共存 词态变化 复数:concomitants; 实用场景例句 全部 伴随的 Cultures that were better at trading saw aconcomitantincrease in their wealth... ...
Background: Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs, including paclitaxel. There is large interindividual variability in the neuropathy, and several risk factors have been proposed; however, many have not been replicated. Here we present a comprehensive study aimed ...